Showing results (31-40 of 112) with videos related to
Sort By:
Pageof 12
Giornale Italiano Di Cardiologia (2006)|April 29, 2026
[Cholesterol metabolism in patients with cancer: pathophysiology, therapeutic options, and future perspectives]Irma Bisceglia, Lorenzo Tinti, Daniele Pastori, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 17, 2016
Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitorsNicola Maurea, Carmela Coppola, Giovanna Piscopo, et al.Journal of Cardiac Failure|February 4, 2012
Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancerLuigi Tarantini, Giovanni Cioffi, Stefania Gori, et al.Oncotargets and Therapy|November 16, 2016
Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle trackingCarmela Coppola, Gennaro Riccio, Antonio Barbieri, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 19, 2014
Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancerGiulia Russo, Giovanni Cioffi, Stefania Gori, et al.European Journal of Heart Failure|January 18, 2013
The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitorsCarlo G Tocchetti, Giuseppina Gallucci, Carmela Coppola, et al.Future Oncology (London, England)|December 21, 2012
Role of preeclampsia-related angiogenic factors in sunitinib cardiotoxicity: two cases and review of the literatureGiuseppina Gallucci, Alfredo Tartarone, Carlo Gabriele Tocchetti, et al.In Vivo (Athens, Greece)|August 31, 2023
Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving TrastuzumabMaria Laura Canale, Giancarlo Casolo, Sara Donati, et al.Antioxidants (Basel, Switzerland)|December 1, 2020
Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical StudiesMassimiliano Berretta, Vincenzo Quagliariello, Nicola Maurea, et al.Breast Cancer Research and Treatment|September 28, 2011
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitorsCarmine Fedele, Gennaro Riccio, Carmela Coppola, et al.Pageof 12